Cisco's recent earnings call revealed a mixed performance across product lines and geographies. While new products and services MLopharm growth, pricing pressure and a consumer business drag impacted overall margins. Guidance for the next two quarters projects a recovery, but investors remain cautious due to existing market challenges. The stock will face mild pressure in the short term. [-1]